These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32860850)

  • 1. Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer.
    Tocci P; Cianfrocca R; Sestito R; Rosanò L; Di Castro V; Blandino G; Bagnato A
    Cancer Lett; 2020 Nov; 492():84-95. PubMed ID: 32860850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
    Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
    Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
    Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP and endothelin-1 signaling: an emerging alliance in cancer.
    Tocci P; Blandino G; Bagnato A
    J Exp Clin Cancer Res; 2021 Jan; 40(1):27. PubMed ID: 33422090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
    Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
    J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.
    Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM
    Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.
    Rosanò L; Cianfrocca R; Sestito R; Tocci P; Di Castro V; Bagnato A
    Expert Opin Ther Targets; 2017 Oct; 21(10):925-932. PubMed ID: 28758529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
    Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
    Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.
    Cianfrocca R; Tocci P; Rosanò L; Caprara V; Sestito R; Di Castro V; Bagnato A
    Oncotarget; 2016 Apr; 7(14):17790-804. PubMed ID: 26909598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK.
    Masi I; Caprara V; Spadaro F; Chellini L; Sestito R; Zancla A; Rainer A; Bagnato A; Rosanò L
    Cell Rep; 2021 Mar; 34(9):108800. PubMed ID: 33657382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
    Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
    Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
    Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
    Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The β-arrestin1/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential.
    Del Rio D; Masi I; Caprara V; Ottavi F; Albertini Petroni G; Salvati E; Trisciuoglio D; Giannitelli SM; Bagnato A; Mauri E; Spadaro F; Rosanò L
    Cell Death Dis; 2024 May; 15(5):358. PubMed ID: 38777849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting mechanoregulation via FAK/YAP to overcome platinum resistance in ovarian cancer.
    Dang LN; Choi J; Lee E; Lim Y; Kwon JW; Park S
    Biomed Pharmacother; 2024 Oct; 179():117335. PubMed ID: 39191020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway.
    Xiao L; Shi XY; Li ZL; Li M; Zhang MM; Yan SJ; Wei ZL
    J Gynecol Oncol; 2021 Sep; 32(5):e77. PubMed ID: 34132072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.
    Rosanò L; Spinella F; Di Castro V; Dedhar S; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Apr; 5(4):833-42. PubMed ID: 16648553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer.
    Tocci P; Caprara V; Cianfrocca R; Sestito R; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2016 Aug; 159():49-54. PubMed ID: 26776837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.